This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2006 Jul 1;24(19):2987-90.

doi: 10.1200/JCO.2005.04.9296.

Rethinking risk-benefit assessment for phase I cancer trials

Steven Joffe¹, Franklin G Miller

Affiliations

PMID: 16809725
DOI: 10.1200/JCO.2005.04.9296

Rethinking risk-benefit assessment for phase I cancer trials

Steven Joffe et al. J Clin Oncol. 2006.

. 2006 Jul 1;24(19):2987-90.

doi: 10.1200/JCO.2005.04.9296.

Authors

Steven Joffe¹, Franklin G Miller

Affiliation

¹ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

PMID: 16809725
DOI: 10.1200/JCO.2005.04.9296

No abstract available

PubMed Disclaimer

Comment in

Phase I trials may not need to be viewed as extraordinarily different from other clinical research.
Sharma S. Sharma S. J Clin Oncol. 2006 Oct 1;24(28):e47. doi: 10.1200/JCO.2006.08.1182. J Clin Oncol. 2006. PMID: 17008685 No abstract available.
Dynamic and modern: bringing the ethics of phase I trials up to date.
Camidge DR, Eckhardt SG, Gore L. Camidge DR, et al. J Clin Oncol. 2006 Nov 10;24(32):5178-9; author reply 5179-80. doi: 10.1200/JCO.2006.09.1207. J Clin Oncol. 2006. PMID: 17093287 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

CA096872/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information